Covidien
00:48 :
Israel's Oridion accepts $23-share bid by Covidien -
TEL AVIV (MarketWatch) -- Oridion Systems Ltd., the Jerusalem provider of medical systems to monitor patients' breathing, definitively agreed to be acquired by Covidien PLC for $23 a share. Covidien is the Dublin provider ...
06:49 :
Covidien to buy Israel's superDimension for $300M -
TEL AVIV (MarketWatch) -- Covidien PLC, the Dublin producer of medical devices, medical supplies and pharmaceuticals, agreed to acquire superDimension Ltd. for $300 million plus potential contingent payments. SuperDimension is the Herzliya, ...
14:26 :
Deaths prompt Covidien to hold surgical stapler inventory -
Medical devices company Covidien plc has issued a voluntary recall for all of its Duet TRS single-use stapling heads, and said they shouldn’t be used in their approved indication, thoracic surgery, after reports of 13 injuries and three ...
08:17 :
Covidien to spin off pharma business -
(Reuters) - Healthcare products and medical device maker Covidien Plc said on Thursday it plans to spin off its pharmaceuticals business into a standalone public company.
11:52 :
Forbes Earnings Preview: Covidien -
Optimism surrounds Covidien (COV), as it gets ready to report its fourth quarter results on Tuesday, November 15, 2011. Analysts are expecting Covidien to book a profit of $1.05 a share, up from 84 cents a year ago.
15:39 :
Covidien hikes quarterly dividend 12.5% -
SAN FRANCISCO (MarketWatch) -- Covidien PLC said late Thursday its board raised the quarterly dividend to 22.5 cents from 20 cents. The dividend is payable Nov. 4 to shareholders as of Oct. 13. Market Pulse Stories are Rapid-fire, short ...
14:51 :
Covidien to open R&D center in China -
Drug and health-care products maker Covidien said Thursday it plans to open a research and development center in Shanghai,
China next year. The 25-member R&D staff that Covidien currently employs in Shanghai ...
08:46 :
Will Covidien Hike Its Dividend Again' -
Covidien Plc (COV - Snapshot Report) operates in the relatively stable health care products industry that offers investors both growth and defense. That's a great thing to have in today's market.
07:11 :
Covidien sets $2 billion stock purchase -
NEW YORK (MarketWatch) -- Covidien PLC said Thursday it'll buy back up to $2 billion of its own stock. "The board's approval of this share repurchase program reflects its confidence in the continued growth of Covidien's business, our sustainable ...
05:20 :
Covidien profit up 47%, helped by lower tax rate -
LONDON (MarketWatch) -- Healthcare products group Covidien PLC said Tuesday that its fiscal third-quarter net profit rose 47% to $535 million, or $1.07 a share, from $364 million, or 72 cents a share, a year earlier. Revenue for the quarter ...
22:14 :
Covidien may sell drugs unit: source -
PHILADELPHIA/BANGALORE (Reuters) - Covidien Plc is looking to sell its pharmaceuticals unit for as much as $4 billion, a source familiar with the situation said on Tuesday.
actualidad Covidien -